Molecular species of R-protein antigens produced by clinical isolates of group B streptococci.

Journal of Clinical Microbiology
A E Flores, P Ferrieri

Abstract

Clinical isolates of group B streptococci from body fluids and mucosal surfaces were examined for production of a trypsin-resistant antigen known as R protein. R protein was extracted with 1% trypsin from cells grown in a semidefined medium. The extracts were tested by immunodiffusion in agarose with a panel of antisera for detection and precise identification of the four species of R protein described by Wilkinson. R antigen was present in 49 of 131 (37%) of the strains tested. Analysis by serotype revealed that 0 of 2 type Ia, 0 of 11 Ib, 1 of 16 (6%) Ia/c, 12 of 15 (80%) II, 0 of 20 II/c, 35 of 49 (71%) III, 0 of 6 IV, and 1 of 12 (8%) nontypeable strains produced R antigen. Production of the R protein and the trypsin-resistant or alpha component of the c protein appeared to be mutually exclusive. R antigen was more prevalent in isolates from blood (50%) than in those from mucosal sites (27%) for type II strains; no difference was seen for type III strains from these sites. Concordant results were obtained with five paired body fluid-mucosal surface isolates from individual patients and with isolates from 17 mother-baby pairs. The most frequent species of R antigen was R4 (45 of 49), followed by R1 (4 of 49). These two speci...Continue Reading

References

Jan 1, 1978·Microbiology and Immunology·S MaekawaY Nakayama
Jul 1, 1988·Reviews of Infectious Diseases·P Ferrieri
Nov 1, 1971·The Journal of Experimental Medicine·J RottaH Lackland
Nov 1, 1971·Infection and Immunity·H W Wilkinson, R G Eagon
Apr 1, 1980·Infection and Immunity·R B CareyR M Swenson
Jan 1, 1983·International Archives of Allergy and Applied Immunology·V LindénP Christensen
Jan 1, 1980·Scandinavian Journal of Infectious Diseases·N E Jensen
Sep 1, 1958·The Journal of Experimental Medicine·R C LANCEFIELD
Aug 1, 1943·The Journal of Experimental Medicine·H F SwiftR C Lancefield

❮ Previous
Next ❯

Citations

Oct 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L BevangerJ A Maeland
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·C S LachenauerL C Madoff
Jul 12, 2001·Infection and Immunity·S RiouxB R Brodeur
Dec 6, 2001·The Pediatric Infectious Disease Journal·H D DaviesUNKNOWN Alberta GBS Study Group
Nov 9, 2005·Clinical and Diagnostic Laboratory Immunology·Johan A MaelandRandi Valsoe Lyng
Jul 10, 2009·Clinical and Vaccine Immunology : CVI·Rooyen T MavenyengwaSylvester R Moyo
Feb 15, 2013·Clinical and Vaccine Immunology : CVI·Johan A MaelandRooyen T Mavenyengwa
Oct 16, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A I KvamJ A Maeland
Apr 1, 1996·Pediatric Annals·B M Mercer, R G Briggs
May 12, 2006·Journal of Medical Microbiology·Srinivas V RamaswamyLawrence C Paoletti
Nov 9, 2004·Folia Microbiologica·E TkacikovaA Dmitriev
Nov 13, 2004·Clinical and Diagnostic Laboratory Immunology·Johan A MaelandRandi Valsoe Lyng
Jan 18, 2005·Clinical Microbiology Reviews·Gunnar LindahlThomas Areschoug
Sep 2, 2009·Microbiology and Molecular Biology Reviews : MMBR·Angela H NobbsHoward F Jenkinson
Oct 23, 2010·Indian Journal of Medical Microbiology·R T MavenyengwaS R Moyo
Mar 6, 1999·Microbiology and Molecular Biology Reviews : MMBR·W W Navarre, O Schneewind
Mar 16, 2019·Microbiology Spectrum·Lawrence C Paoletti, Dennis L Kasper
Dec 1, 1990·Journal of Clinical Microbiology·I W Wibawan, C Lämmler
Jul 11, 2006·Journal of Clinical Microbiology·Srinivas V RamaswamyLawrence C Paoletti
Oct 1, 1993·Journal of Clinical Microbiology·E FasolaP Ferrieri
Jul 26, 2002·International Journal of Medical Microbiology : IJMM·Jeffrey A BensonPatricia Ferrieri
Dec 30, 2014·Clinical and Vaccine Immunology : CVI·Johan A MaelandAndreas Radtke
Aug 1, 1991·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·I W Wibawan, C Lämmler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology
Aurea E Flores, P Ferrieri
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology
V LindénP Christensen
Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
Aurea E Flores, P Ferrieri
© 2022 Meta ULC. All rights reserved